These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3351365

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy.
    Hayakawa M, Maki M.
    Gynecol Obstet Invest; 1988; 26(3):181-90. PubMed ID: 3240888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Relationship between coagulation-fibrinolysis kinetics and the severity and predictability of toxemia of pregnancy].
    Musha T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):33-40. PubMed ID: 2926193
    [Abstract] [Full Text] [Related]

  • 6. [Physiopathology of kinin forming system in reproduction].
    Soga K, Maki M, Sasaki T, Motoyama Y.
    Rinsho Ketsueki; 1989 Oct; 30(10):1713-22. PubMed ID: 2593238
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S, Kobayashi M, Hirata J, Itoh N, Maki M, Komatsu Y, Yoshida A, Sasa H, Kuroda K, Kikuchi Y.
    Agents Actions Suppl; 1992 Oct; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [Abstract] [Full Text] [Related]

  • 12. [Fibrinolysis in pregnancy toxemia].
    Kano A.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2311-20. PubMed ID: 6607299
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Physiological and pathological significance of plasma prekallikrein in obstetrics].
    Soga K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1763-72. PubMed ID: 6924684
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS, Gallin JI, Kaplan AP.
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of coagulation-fibrinolysis factors in normal pregnancy, labor and puerperium and in cesarean section delivery.
    Tei A, Mutoh S, Yaoi Y, Saito M.
    Bull Tokyo Med Dent Univ; 1989 Jun; 36(2):19-26. PubMed ID: 2776281
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
    Sucak GT, Acar K, Sucak A, Kirazli S, Haznedar R.
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.